srch

The latest tweets from @FierceBiotech

Fierce Biotech's JPM 2022 coverage all in one place. Dealmaking, R&D updates and biotech trends: Follow our coverage of the virtual JPM 2022.

The Fierce Biotech team goes beyond the daily with comprehensive coverage of medical meetings and industry confabs, plus special reports that highlight up-and-comers and shed new light on industry heavyweights. View Sample Newsletter. Register and select your free newsletters. Email Address:

19.12.2021 · Fierce Biotech | 12,704 followers on LinkedIn. We are Fierce – everywhere you need us to be. | Providing end-to-end coverage of biotech and medtech, from pre-clinical science through clinical ...

“Slowing down was not an option for our 2021 Fierce 15 winners. From a biotech exploring a new type of viral vector for gene therapies to one ...

Fierce Biotech's JPM 2022 coverage all in one place. Dealmaking, R&D updates and biotech trends: Follow our coverage of the virtual JPM 2022.

Visit FiercePharma for pharma industry news on big pharma, FDA decisions, patents, pharmaceutical marketing, generic drugs, and other pharma news.

Fierce Biotech. WHAT TO EXPECT. This conference provides a unique networking opportunity, featuring insights from C-suite and executive leadership at ...

27.09.2021 · Fierce Biotech's 2021 Fierce 15. While speaking to a number of venture capitalists this year, we picked their brains on how to choose life …

Read the latest biotechnology articles on biotech industry leaders, emerging biotech companies, FDA decisions, VC deals, and other biotech industry news.

Our Editors provide end-to-end coverage of biotech and medtech, from pre-clinical science through clinical testing and regulatory approval——and all the seed ...

FierceBiotech, Washington D. C. 3,942 likes · 17 talking about this. FierceBiotech is the largest, most actively read biotechnology news publication in …

Every business day, Fierce Biotech and its family of publications covers the waterfront in drug development and MedTech, from pre-clinical science to seed ...

The latest tweets from @FierceBiotech

03.02.2022 · Pfizer, Merck, Bayer and Volastra have already partnered with Dewpoint Therapeutics across neuromuscular conditions, HIV, cancer metastasis and cardiopulmonary diseases. Now, the Boston biotech ...

Providing end-to-end coverage of biotech and medtech, from pre-clinical science through clinical testing and regulatory approval—and all the seed funding, ...

Novartis splashes cash on COVID-19 antiviral, plans FDA filing. Molecular Partners linked ensovibep to a 78% risk reduction in an earlier-stage population, prompting Novartis to …

Unity Biotechnology will let go half its staff, shift focus to eye disease assets and pause work in neurology and other programs. fiercebiotech.com.

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on Fierce Biotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Every business day, Fierce Biotech and its family of publications covers the waterfront in drug development and MedTech, from pre ...

FierceBiotech is the most widely read biotechnology news source in the world. Editor-in-chief John Carroll leads our team of full-time journalists bringing you a daily dish of original biotechnology news, covering biopharma M&A and licensing, clinical trials, FDA decisions, and more.

Fierce Biotech. 4,990 followers. 5h. Report this post. A four-drug combination including immunotherapy, chemo and a CSF1R inhibitor could be a strategy for treating NSCLC, a new study shows. # ...